Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in Regenerative Medicine dealmaking

 

2.1. Introduction

2.2. Regenerative Medicine partnering over the years

2.3. Most active Regenerative Medicine dealmakers

2.4. Regenerative Medicine partnering by deal type

2.5. Regenerative Medicine partnering by therapy area

2.6. Deal terms for Regenerative Medicine partnering

2.6.1 Regenerative Medicine partnering headline values

2.6.2 Regenerative Medicine deal upfront payments7

2.6.3 Regenerative Medicine deal milestone payments

2.6.4 Regenerative Medicine royalty rates

 

Chapter 3 – Leading Regenerative Medicine deals

 

3.1. Introduction

3.2. Top Regenerative Medicine deals by value

 

Chapter 4 – Most active Regenerative Medicine dealmakers

 

4.1. Introduction

4.2. Most active Regenerative Medicine dealmakers

4.3. Most active Regenerative Medicine partnering company profiles

 

Chapter 5 – Regenerative Medicine contracts dealmaking directory

 

5.1. Introduction

5.2. Regenerative Medicine contracts dealmaking directory

 

Chapter 6 – Regenerative Medicine dealmaking by technology type

 

Chapter 7 – Partnering resource center

 

7.1. Online partnering

7.2. Partnering events

7.3. Further reading on dealmaking

 

Appendices

 

Appendix 1 – Regenerative Medicine deals by company A-Z

 

Appendix 2 – Regenerative Medicine deals by stage of development

 

Discovery

Preclinical

Phase I

Phase II

Phase III

Regulatory

Marketed

Formulation

 

Appendix 3 – Regenerative Medicine deals by deal type

 

Asset purchase

Assignment

Bigpharma outlicensing

Co-development

Collaborative R&D

Co-market

Co-promotion

CRADA

Cross-licensing

Development

Distribution

Equity purchase

Evaluation        

Grant

Joint venture

Licensing

Litigation

Manufacturing

Marketing

Material transfer

Option

Promotion

Research

Settlement

Spin out

Sub-license

Supply

Technology transfer

Termination

Warranty

 

Appendix 4 – Regenerative Medicine deals by therapy area

 

Appendix 5 –Deal type definitions

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Regenerative Medicine partnering since 2012

Figure 2: Active Regenerative Medicine dealmaking activity– 2012 to 2018

Figure 3: Regenerative Medicine partnering by deal type since 2012

Figure 4: Regenerative Medicine partnering by disease type since 2012

Figure 5: Regenerative Medicine deals with a headline value

Figure 6: Regenerative Medicine deals with an upfront value

Figure 7: Regenerative Medicine deals with a milestone value

Figure 8: Regenerative Medicine deals with a royalty rate value

Figure 9: Top Regenerative Medicine deals by value since 2012

Figure 10: Most active Regenerative Medicine dealmakers 2012 to 2018

Figure 11: Online partnering resources

Figure 12: Forthcoming partnering events